Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 228

1.

The epidemiology of antiretroviral drug resistance among drug-naive HIV-1-infected persons in 10 US cities.

Weinstock HS, Zaidi I, Heneine W, Bennett D, Garcia-Lerma JG, Douglas JM Jr, LaLota M, Dickinson G, Schwarcz S, Torian L, Wendell D, Paul S, Goza GA, Ruiz J, Boyett B, Kaplan JE.

J Infect Dis. 2004 Jun 15;189(12):2174-80. Epub 2004 May 21.

PMID:
15181563
2.

Prevalence of antiretroviral drug resistance mutations in chronically HIV-infected, treatment-naive patients: implications for routine resistance screening before initiation of antiretroviral therapy.

Novak RM, Chen L, MacArthur RD, Baxter JD, Huppler Hullsiek K, Peng G, Xiang Y, Henely C, Schmetter B, Uy J, van den Berg-Wolf M, Kozal M; Terry Beirn Community Programs for Clinical Research on AIDS 058 Study Team.

Clin Infect Dis. 2005 Feb 1;40(3):468-74. Epub 2005 Jan 10.

PMID:
15668873
3.

Primary drug resistance in antiretroviral-naïve injection drug users.

Tossonian HK, Raffa JD, Grebely J, Viljoen M, Mead A, Khara M, McLean M, Krishnamurthy A, DeVlaming S, Conway B.

Int J Infect Dis. 2009 Sep;13(5):577-83. doi: 10.1016/j.ijid.2008.08.028. Epub 2008 Dec 25.

4.

Prevalence of HIV-1 resistant to antiretroviral drugs in 81 individuals newly infected by sexual contact or injecting drug use. Investigators of the Quebec Primary Infection Study.

Salomon H, Wainberg MA, Brenner B, Quan Y, Rouleau D, Coté P, LeBlanc R, Lefebvre E, Spira B, Tsoukas C, Sekaly RP, Conway B, Mayers D, Routy JP.

AIDS. 2000 Jan 28;14(2):F17-23.

PMID:
10708278
5.

The prevalence of resistance-associated mutations to protease and reverse transcriptase inhibitors in treatment-naïve (HIV1)-infected individuals in Casablanca, Morocco.

Bakhouch K, Oulad-Lahcen A, Bensghir R, Blaghen M, Elfilali KM, Ezzikouri S, Abidi O, Hassar M, Wakrim L.

J Infect Dev Ctries. 2009 Jun 1;3(5):380-91.

6.

Low prevalence of antiretroviral resistance among persons recently infected with human immunodeficiency virus in two US cities.

Sullivan PS, Buskin SE, Turner JH, Cheingsong R, Saekhou A, Kalish ML, Jones JL, Respess R, Kovacs A, Heneine W.

Int J STD AIDS. 2002 Aug;13(8):554-8.

PMID:
12194739
7.

Prevalence of genotypic and phenotypic resistance to anti-retroviral drugs in a cohort of therapy-naïve HIV-1 infected US military personnel.

Wegner SA, Brodine SK, Mascola JR, Tasker SA, Shaffer RA, Starkey MJ, Barile A, Martin GJ, Aronson N, Emmons WW, Stephan K, Bloor S, Vingerhoets J, Hertogs K, Larder B.

AIDS. 2000 May 26;14(8):1009-15.

PMID:
10853983
8.

Prevalence of resistance mutations in antiretroviral-naive chronically HIV-infected patients in 1998: a French nationwide study.

Descamps D, Calvez V, Izopet J, Buffet-Janvresse C, Schmuck A, Colson P, Ruffault A, Maillard A, Masquelier B, Cottalorda J, Harzic M, Brun-Vézinet F, Costagliola D; ANRS Antiretroviral Resistance Study Group.

AIDS. 2001 Sep 28;15(14):1777-82.

PMID:
11579238
9.

Antiretroviral resistance among HIV-infected persons who have died in British Columbia, in the era of modern antiretroviral therapy.

Recsky MA, Brumme ZL, Chan KJ, Wynhoven B, Yip B, Dong WW, Heath KV, Montaner JS, Levy AR, Hogg RS, Harrigan PR.

J Infect Dis. 2004 Jul 15;190(2):285-92. Epub 2004 Jun 11.

PMID:
15216463
10.

Prevalence of mutations associated with reduced antiretroviral drug susceptibility among human immunodeficiency virus type 1 seroconverters in the United States, 1993-1998.

Weinstock H, Respess R, Heneine W, Petropoulos CJ, Hellmann NS, Luo CC, Pau CP, Woods T, Gwinn M, Kaplan J.

J Infect Dis. 2000 Jul;182(1):330-3. Epub 2000 Jun 13.

PMID:
10882618
11.
12.

Prevalence of drug-resistant human immunodeficiency virus type 1 in therapy-naive patients and usefulness of genotype testing.

Ibe S, Hotta N, Takeo U, Tawada Y, Mamiya N, Yamanaka K, Utsumi M, Kaneda T.

Microbiol Immunol. 2003;47(7):499-505.

13.

Prevalence of drug resistance and newly recognised treatment-related substitutions in the HIV-1 reverse transcriptase and protease genes from HIV-positive patients naïve for anti-retrovirals.

Torti C, Bono L, Gargiulo F, Uccelli MC, Quiros-Roldan E, Patroni A, Paraninfo G, Tirelli V, Manca N, De Francesco MA, Perandin F, Carosi G.

Clin Microbiol Infect. 2004 Sep;10(9):826-30.

14.

Prevalence of resistance-associated mutations in newly diagnosed HIV-1 patients in Greece.

Paraskevis D, Magiorkinis E, Katsoulidou A, Hatzitheodorou E, Antoniadou A, Papadopoulos A, Poulakou G, Paparizos V, Botsi C, Stavrianeas N, Lelekis M, Chini M, Gargalianos P, Magafas N, Lazanas M, Chryssos G, Petrikkos G, Panos G, Kordossis T, Theodoridou M, Sypsa V, Hatzakis A; Hellenic Multi-centre study on HIV-resistance.

Virus Res. 2005 Sep;112(1-2):115-22. Epub 2005 Apr 8.

PMID:
16022906
15.

A genotyping study of human immunodeficiency virus type-1 drug resistance in a small Brazilian municipality.

Eyer-Silva WA, Morgado MG.

Mem Inst Oswaldo Cruz. 2005 Dec;100(8):869-73. Epub 2006 Jan 20.

16.

Drug-resistance mutations in antiretroviral-naïve patients with established HIV-1 infection in Mexico.

Escoto-Delgadillo M, Vázquez-Valls E, Ramírez-Rodríguez M, Corona-Nakamura A, Amaya-Tapia G, Quintero-Pérez N, Panduro-Cerda A, Torres-Mendoza BM.

HIV Med. 2005 Nov;6(6):403-9.

17.

Analysis of drug resistance-associated mutations in treatment-naïve individuals infected with different genetic forms of HIV-1 circulating in countries of the former Soviet Union.

Vázquez de Parga E, Rakhmanova A, Pérez-Alvarez L, Vinogradova A, Delgado E, Thomson MM, Casado G, Sierra M, Muñoz M, Carmona R, Vega Y, Contreras G, Medrano L, Osmanov S, Nájera R.

J Med Virol. 2005 Nov;77(3):337-44.

PMID:
16173024
18.

Increasing prevalence of transmitted drug resistance mutations and non-B subtype circulation in antiretroviral-naive chronically HIV-infected patients from 2001 to 2006/2007 in France.

Descamps D, Chaix ML, Montes B, Pakianather S, Charpentier C, Storto A, Barin F, Dos Santos G, Krivine A, Delaugerre C, Izopet J, Marcelin AG, Maillard A, Morand-Joubert L, Pallier C, Plantier JC, Tamalet C, Cottalorda J, Desbois D, Calvez V, Brun-Vezinet F, Masquelier B, Costagliola D; ANRS AC11 Resistance Study Group.

J Antimicrob Chemother. 2010 Dec;65(12):2620-7. doi: 10.1093/jac/dkq380. Epub 2010 Oct 21.

PMID:
20965891
19.

Antiretroviral drug resistance among HIV-1 infected children failing treatment.

Mullen J, Leech S, O'Shea S, Chrystie IL, Du Mont G, Ball C, Sharland M, Cottam F, Zuckerman M, Rice P, Easterbrook P.

J Med Virol. 2002 Nov;68(3):299-304.

PMID:
12226814
20.

Prevalence and impact of HIV-1 protease codon 33 mutations and polymorphisms in treatment-naive and treatment-experienced patients.

Kozal MJ, Hullsiek KH, Leduc R, Novak RM, MacArthur RD, Lawrence J, Baxter JD; Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA).

Antivir Ther. 2006;11(4):457-63.

PMID:
16856619

Supplemental Content

Support Center